Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Navid Sobhani, Dana Rae Tardiel-Cyril, Aram Davtyan, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1440-1440
Open Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 253
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 76
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 50
Regulation of Treg cells by cytokine signaling and co-stimulatory molecules
Yuan Zong, Kaihang Deng, Wai Po Chong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 24
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Yan-Ruide Li, Tyler Halladay, Lili Yang
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 22
Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation
Michael Li, Sherrie Bhoori, Neil Mehta, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 4, pp. 743-755
Closed Access | Times Cited: 15
Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
Yang Liu, Xingyue Wang, Shu‐Rong Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189259-189259
Open Access | Times Cited: 2
Hematologic complications of immune checkpoint inhibitors
Michael H. Kroll, Cristhiam M. Rojas‐Hernandez, Cassian Yee
Blood (2021) Vol. 139, Iss. 25, pp. 3594-3604
Open Access | Times Cited: 57
Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials
Dhananjay Yadav, Minseok Kwak, Pallavi Chauhan, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 909-922
Closed Access | Times Cited: 43
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El‐Deiry
Cancers (2022) Vol. 14, Iss. 4, pp. 1028-1028
Open Access | Times Cited: 41
Photodynamic therapy based on porphyrin-based metal–organic frameworks
D.Y. Xu, Qian Duan, Hui Yu, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 26, pp. 5976-5989
Closed Access | Times Cited: 39
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 39
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
Guanglong Ma, Weifeng Lin
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 35
Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy
Sara Gomes, Ana Rodrigues, Valerio Pazienza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5069-5069
Open Access | Times Cited: 26
Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Wei Zhang, Yifei Tan, Yuquan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Advances in immunotherapy for cervical cancer
Juan Francisco Grau-Béjar, Carmen García-Durán, David García-Illescas, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 23
Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
Yi-Shan Teng, Sebastian Yu
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6805-6819
Open Access | Times Cited: 22
High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome
Nithya Krishnamurthy, Daisuke Nishizaki, Scott M. Lippman, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 9
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
S Mestiri, Dina Moustafa Abo El-Ella, Queenie Fernandes, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116095-116095
Open Access | Times Cited: 8
A Narrative Review of Current Knowledge on Cutaneous Melanoma
Bogdan Marian Caraban, Mariana Aşchie, Mariana Deacu, et al.
Clinics and Practice (2024) Vol. 14, Iss. 1, pp. 214-241
Open Access | Times Cited: 8
Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-onset Type 1 Diabetes
Zhaoxin Yang, Zhirang Zhang, Liyan Li, et al.
Diabetes (2024) Vol. 73, Iss. 8, pp. 1325-1335
Open Access | Times Cited: 8
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
Song-Xin Zhu, Yuming Wang, Jun Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
Vicky Mengfei Qin, Nicole M. Haynes, Criselle D’Souza, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 33
Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism
Annabelle Emery, Sally Moore, James Turner, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top